Alexander H. Wu

Taipei, TNQ 11031, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 121 publications

Phenotype-Oriented Characterization of NSC828786 Identifies Convergent HPN-AMACR-Associated Transcriptomic Signatures in Prostate Adenocarcinoma and Broad-Spectrum Antiproliferative Activity.

Phenotype-Oriented Characterization of NSC828786 Identifies Convergent HPN-AMACR-Associated Transcriptomic Signatures in Prostate Adenocarcinoma and Broad-Spectrum Antiproliferative Activity.

Journal: Cells

Published: May 28, 2026

Effect of Morus alba L. Fruit Extract on Sperm Quality, Testosterone Profile, and Testicular Histology in Male Rats.

Effect of Morus alba L. Fruit Extract on Sperm Quality, Testosterone Profile, and Testicular Histology in Male Rats.

Journal: Life (Basel, Switzerland)

Published: May 01, 2026

Corrigendum "Preclinical anti-inflammatory and antioxidant effects of Azanza garckeana in STZ-induced glycemic-impaired rats, and pharmacoinformatics of it major phytoconstituents" [Biomed. Pharmacother. 152 (2022) 113196].

Corrigendum "Preclinical anti-inflammatory and antioxidant effects of Azanza garckeana in STZ-induced glycemic-impaired rats, and pharmacoinformatics of it major phytoconstituents" [Biomed. Pharmacother. 152 (2022) 113196].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 19, 2026

Pathology-tailored nanotherapy via Galectin-3-targeted and triple-responsive nanoparticles enables multimodal therapy against aortic dissection.

Pathology-tailored nanotherapy via Galectin-3-targeted and triple-responsive nanoparticles enables multimodal therapy against aortic dissection.

Journal: Journal of nanobiotechnology

Published: August 22, 2025

Integrated In Silico and Experimental Validation of Antrocin as a Plant-Derived Multi-Target Therapeutic for BRAF/MEK/PI3K-Driven Colorectal Cancer.

Integrated In Silico and Experimental Validation of Antrocin as a Plant-Derived Multi-Target Therapeutic for BRAF/MEK/PI3K-Driven Colorectal Cancer.

Journal: International journal of molecular sciences

Published: July 17, 2025

Machine learning-driven discovery of NSC828779 as a multi-mechanistic NLRP3 inflammasome inhibitor for inflammatory diseases.

Machine learning-driven discovery of NSC828779 as a multi-mechanistic NLRP3 inflammasome inhibitor for inflammatory diseases.

Journal: Computers in biology and medicine

Published: May 25, 2025

Programmable MRI contrast switching for spatiotemporal mapping of thrombus maturation via enzyme-directed nanoprobe reconfiguration.

Programmable MRI contrast switching for spatiotemporal mapping of thrombus maturation via enzyme-directed nanoprobe reconfiguration.

Journal: Nano convergence

Published: May 22, 2025

Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60.

Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60.

Journal: Computers in biology and medicine

Published: April 20, 2025

Bioprospection of Hura crepitans metabolites against oxidative stress and inflammation: An in vitro and in silico exploration.

Bioprospection of Hura crepitans metabolites against oxidative stress and inflammation: An in vitro and in silico exploration.

Journal: International journal of medical sciences

Published: December 20, 2024

Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub.

Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub.

Journal: International journal of medical sciences

Published: November 19, 2024

In Silico Identification of ANKRD22 as a Theragnostic Target for Pancreatic Cancer and Fostamatinib's Therapeutic Potential.

In Silico Identification of ANKRD22 as a Theragnostic Target for Pancreatic Cancer and Fostamatinib's Therapeutic Potential.

Journal: International journal of medical sciences

Published: October 14, 2024

Corrigendum to "Development and functional evaluation of a hyaluronic acid coated nano-formulation with kaempferol as a novel intra-articular agent for knee osteoarthritis treatment"[ Biomed. Pharmacother. 175(2024) 116717].

Corrigendum to "Development and functional evaluation of a hyaluronic acid coated nano-formulation with kaempferol as a novel intra-articular agent for knee osteoarthritis treatment"[ Biomed. Pharmacother. 175(2024) 116717].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 21, 2024

Showing 1-12 of 121

Last Updated: 09/26/2026